Published in Retina on February 01, 2008
Outcome and significance of silicone oil tamponade in patients with chronic serous retinal detachment. Korean J Ophthalmol (2014) 0.75
Internal drainage for chronic macula-involving serous retinal detachment in idiopathic central serous chorioretinopathy. Int Ophthalmol (2013) 0.75
Ranibizumab for neovascular age-related macular degeneration. N Engl J Med (2006) 30.63
Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med (2006) 20.84
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology (2012) 8.29
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology (2009) 6.44
Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol (2003) 4.78
Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med (2008) 3.92
Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis. Retina (2013) 2.49
The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology (2013) 2.35
Evaluation of wound closure in oblique 23-gauge sutureless sclerotomies with visante optical coherence tomography. Am J Ophthalmol (2008) 2.26
Utility of intraoperative optical coherence tomography during vitrectomy surgery for vitreomacular traction syndrome. Retina (2014) 2.15
Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema. Am J Ophthalmol (2005) 1.99
Intrasurgical dynamics of macular hole surgery: an assessment of surgery-induced ultrastructural alterations with intraoperative optical coherence tomography. Retina (2014) 1.97
RESOLUTION OF NONINFECTIOUS UVEITIC CYSTOID MACULAR EDEMA WITH TOPICAL DIFLUPREDNATE. Retina (2017) 1.96
Novel microarchitectural dynamics in rhegmatogenous retinal detachments identified with intraoperative optical coherence tomography. Retina (2013) 1.96
Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore) (2003) 1.94
Optical coherence tomography enhanced depth imaging of choroidal tumors. Am J Ophthalmol (2011) 1.91
Short-term outcomes of 23-gauge pars plana vitrectomy. Am J Ophthalmol (2008) 1.89
Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome. Br J Ophthalmol (2013) 1.86
Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration. Ophthalmology (2009) 1.86
Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp Cell Res (2006) 1.82
Removal of retained subfoveal perfluoro-n-octane liquid. Am J Ophthalmol (2004) 1.77
Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. Am J Ophthalmol (2003) 1.74
Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina (2007) 1.68
Panretinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser. Am J Ophthalmol (2011) 1.62
Optical coherence tomography 3: Automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. Invest Ophthalmol Vis Sci (2004) 1.62
Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol (2006) 1.62
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology (2008) 1.60
Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma. Am J Ophthalmol (2007) 1.56
Chest computerized tomography in the evaluation of uveitis in elderly women. Am J Ophthalmol (2002) 1.55
Impact of ocular surface symptoms on quality of life in a United States veterans affairs population. Am J Ophthalmol (2012) 1.53
Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab. Ophthalmology (2009) 1.52
Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology (2006) 1.46
Adverse events after intravitreal triamcinolone in patients with and without uveitis. Ophthalmology (2007) 1.45
Prevalence of outer retinal tubulation after anti-VEGF therapy for age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina (2015) 1.42
Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surg Lasers Imaging (2005) 1.38
Neovascular age-related macular degeneration: potential therapies. Drugs (2008) 1.38
Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol (2002) 1.35
Use of ultra-high-resolution optical coherence tomography to detect in vivo characteristics of Descemet's membrane in Fuchs' dystrophy. Ophthalmology (2010) 1.33
Aflibercept for age-related macular degeneration: a game-changer or quiet addition? Am J Ophthalmol (2012) 1.31
Visualization and characterization of inflammatory cell recruitment and migration through the corneal stroma in endotoxin-induced keratitis. Invest Ophthalmol Vis Sci (2006) 1.29
Diagnosis and management of conjunctival and corneal intraepithelial neoplasia using ultra high-resolution optical coherence tomography. Ophthalmology (2011) 1.25
Bone marrow chimeras and c-fms conditional ablation (Mafia) mice reveal an essential role for resident myeloid cells in lipopolysaccharide/TLR4-induced corneal inflammation. J Immunol (2009) 1.23
Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis. Ophthalmology (2004) 1.20
Keratocan and lumican regulate neutrophil infiltration and corneal clarity in lipopolysaccharide-induced keratitis by direct interaction with CXCL1. J Biol Chem (2007) 1.18
Evaluation of choroidal thickness in retinitis pigmentosa using enhanced depth imaging optical coherence tomography. Br J Ophthalmol (2012) 1.17
Epidemiology and visual outcomes in patients with infectious scleritis. Cornea (2013) 1.15
A novel segmentation algorithm for volumetric analysis of macular hole boundaries identified with optical coherence tomography. Invest Ophthalmol Vis Sci (2013) 1.13
Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma. Acta Ophthalmol (2010) 1.12
Diagnosis of ocular surface lesions using ultra-high-resolution optical coherence tomography. Ophthalmology (2013) 1.12
Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative database. Am J Ophthalmol (2012) 1.12
A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration. Mol Neurobiol (2010) 1.10
A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration. Ophthalmology (2010) 1.10
Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol (2006) 1.09
Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant. Am J Ophthalmol (2006) 1.09
Ultra-high resolution optical coherence tomography for imaging the anterior segment of the eye. Ophthalmic Surg Lasers Imaging (2011) 1.06
Ocular manifestations of ANCA-associated vasculitis. Rheum Dis Clin North Am (2010) 1.06
Contrast-enhanced intraoperative optical coherence tomography. Br J Ophthalmol (2013) 1.06
Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study. Br J Ophthalmol (2006) 1.05
Comparison of retinal thickness measurements between three-dimensional and radial scans on spectral-domain optical coherence tomography. Am J Ophthalmol (2009) 1.05
Ocular surface parameters in older male veterans. Invest Ophthalmol Vis Sci (2013) 1.04
Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration. Int J Inflam (2013) 1.04
Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci (2007) 1.03
Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis. Ophthalmology (2011) 1.02
Reopening of previously closed macular holes after cataract extraction. Am J Ophthalmol (2007) 1.02
VESGEN 2D: automated, user-interactive software for quantification and mapping of angiogenic and lymphangiogenic trees and networks. Anat Rec (Hoboken) (2009) 1.01
Anterior segment and external ocular disorders associated with human immunodeficiency virus disease. Surv Ophthalmol (2007) 1.01
Retinal and choroidal vascular occlusion after posterior sub-tenon triamcinolone injection. Am J Ophthalmol (2002) 1.00
Triamcinolone acetonide inhibits IL-6- and VEGF-induced angiogenesis downstream of the IL-6 and VEGF receptors. Invest Ophthalmol Vis Sci (2006) 0.99
International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep (2013) 0.99
Outcome of fluocinolone acetonide implant (Retisert) reimplantation for chronic noninfectious posterior uveitis. Retina (2008) 0.98
Stereotactic low-voltage x-ray irradiation for age-related macular degeneration. Br J Ophthalmol (2010) 0.98
Comparing retinal thickness measurements using automated fast macular thickness map versus six-radial line scans with manual measurements. Ophthalmology (2009) 0.98
Evaluation of wound closure using different incision techniques with 23-gauge and 25-gauge microincision vitrectomy systems. Retina (2008) 0.97
Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular tree by triamcinolone acetonide. Invest Ophthalmol Vis Sci (2008) 0.97
In vivo gene delivery and visualization of corneal stromal cells using an adenoviral vector and keratocyte-specific promoter. Invest Ophthalmol Vis Sci (2004) 0.97
Emerging treatments for wet age-related macular degeneration. Expert Opin Emerg Drugs (2014) 0.96
3D Spectral domain optical coherence tomography findings in choroidal tumors. Eur J Ophthalmol (2011) 0.96
Sarcoidosis. Curr Opin Ophthalmol (2007) 0.96
Choroidal thickness in macular holes: a case-control study. Ophthalmic Surg Lasers Imaging Retina (2015) 0.95
Endophthalmitis after 25-gauge transconjunctival sutureless vitrectomy. Retina (2006) 0.94
Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration. Ophthalmology (2009) 0.94